找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Urological Oncology; Vinod H. Nargund (Chair, Uro-Oncology MDT and Cons Book 20081st edition Springer-Verlag London 2008 Staging.TNM stagi

[復(fù)制鏈接]
查看: 47566|回復(fù): 55
樓主
發(fā)表于 2025-3-21 18:09:52 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書目名稱Urological Oncology
編輯Vinod H. Nargund (Chair, Uro-Oncology MDT and Cons
視頻videohttp://file.papertrans.cn/945/944325/944325.mp4
概述An easy-to-look-up reference guide to step-by-step management strategies and drug dosages designed mainly for the trainee doctor in an emergency situation.Practical guide and not theoretical discourse
圖書封面Titlebook: Urological Oncology;  Vinod H. Nargund (Chair, Uro-Oncology MDT and Cons Book 20081st edition Springer-Verlag London 2008 Staging.TNM stagi
描述Urological oncology is a subject of enormous interest to large numbers of uro- gists throughout the world, particularly with our increasing understanding of the possible causes and pathogenesis of the condition. As Editor-in-Chief of one of the urological journals, I can attest to this interest; the largest percentage of the papers I receive for review each year relate to either clinical or experime- tal urological oncology. It used to be that the manuscripts concerned mainly surgical techniques, but now this has extended to new technologies, dia- nostic methods, randomized pharmaceutical clinical trials, and thoughtful and complex experimental studies into the genesis of urological cancer. This is all evidence of our increasing interest in the topic. In addition to this, we have come to understand the management of urolo- cal cancer is not in the hands of a single discipline. The advent of multidis- plinary team meetings has made us realize that there is a hugely signi? cant role to be played by urologists, medical oncologists, radiation oncologists, patho- gists, and radiologists. This new dimension has been driven by the advent of new therapies and by closer interaction among al
出版日期Book 20081st edition
關(guān)鍵詞Staging; TNM staging system; Tumor; Urological Oncology; cancers; carcinoma; classification; diagnosis; geni
版次1
doihttps://doi.org/10.1007/978-1-84628-738-1
isbn_ebook978-1-84628-738-1
copyrightSpringer-Verlag London 2008
The information of publication is updating

書目名稱Urological Oncology影響因子(影響力)




書目名稱Urological Oncology影響因子(影響力)學(xué)科排名




書目名稱Urological Oncology網(wǎng)絡(luò)公開度




書目名稱Urological Oncology網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Urological Oncology被引頻次




書目名稱Urological Oncology被引頻次學(xué)科排名




書目名稱Urological Oncology年度引用




書目名稱Urological Oncology年度引用學(xué)科排名




書目名稱Urological Oncology讀者反饋




書目名稱Urological Oncology讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:31:31 | 只看該作者
板凳
發(fā)表于 2025-3-22 02:04:31 | 只看該作者
Principles of Chemotherapy for Genitourinary Cancerst century, insight into the intracellular pathways that result in sensitivity and resistance of the neoplastic cells to drug treatment have led to significant refinement of our technology, leading to more effective and less toxic treatment regimens.
地板
發(fā)表于 2025-3-22 06:50:27 | 只看該作者
5#
發(fā)表于 2025-3-22 09:48:30 | 只看該作者
6#
發(fā)表于 2025-3-22 13:07:12 | 只看該作者
7#
發(fā)表于 2025-3-22 20:57:22 | 只看該作者
8#
發(fā)表于 2025-3-22 21:56:32 | 只看該作者
Anesthesic Considerations in Genitourinary Cancer Patientscation among the different disciplines involved in the patient’s care. Surgical intervention in patients with urological malignancy must balance the benefits of early surgery, and the risks to patients, many of whom have preexisting conditions requiring investigation, treatment, and optimization.
9#
發(fā)表于 2025-3-23 01:55:55 | 只看該作者
10#
發(fā)表于 2025-3-23 09:02:07 | 只看該作者
Clinical Trials and Their Principlesapter introduces clinical trials in this context. The discussion largely focuses on the design and implementation of a clinical trial in its various stages. Possible sources of bias in clinical trials and methods of minimizing or eliminating this bias are also discussed.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-22 04:12
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
迁西县| 息烽县| 清水县| 镇远县| 富川| 交口县| 吉林市| 东阳市| 洞头县| 新干县| 静乐县| 锦屏县| 旬邑县| 隆化县| 榕江县| 宣化县| 龙门县| 塔河县| 九江市| 庄浪县| 永安市| 湘潭市| 岑巩县| 沐川县| 海晏县| 塔河县| 乡宁县| 宁远县| 麻江县| 高要市| 田阳县| 金湖县| 肥西县| 临沭县| 芜湖县| 读书| 奇台县| 湘西| 滦平县| 彭山县| 贵港市|